Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Volume 1832, Issue 7, Pages 911-921Publisher
ELSEVIER
DOI: 10.1016/j.bbadis.2013.03.001
Keywords
Pulmonary fibrosis; Epithelial cells; Apoptosis; Fibroblasts; Myofibroblasts; Extracellular matrix
Funding
- NIH [R01-HL095732, R01-HL108975]
- Scleroderma Research Foundation
- Coalition for Pulmonary Fibrosis
- Pulmonary Fibrosis Foundation
- Nirenberg Center for Advanced Lung Disease
- Japan Society for the Promotion of Science (JSPS)
Ask authors/readers for more resources
Idiopathic pulmonary fibrosis (IPF) is characterized by the progressive and ultimately fatal accumulation of fibroblasts and extracellular matrix in the lung that distorts its architecture and compromises its function. IPF is now thought to result from wound-healing processes that, although initiated to protect the host from injurious environmental stimuli, lead to pathological fibrosis due to these processes becoming aberrant or over-exuberant. Although the environmental stimuli that trigger IPF remain to be identified, recent evidence suggests that they initially injure the alveolar epithelium. Repetitive cycles of epithelial injury and resultant alveolar epithelial cell death provoke the migration, proliferation, activation and myofibroblast differentiation of fibroblasts, causing the accumulation of these cells and the extracellular matrix that they synthesize. In turn, these activated fibroblasts induce further alveolar epithelial cell injury and death, thereby creating a vicious cycle of pro-fibrotic epithelial cell-fibroblast interactions. Though other cell types certainly make important contributions, we focus here on the pas de deux (steps of two), or perhaps more appropriate to IPF pathogenesis, the folie a deux (madness of two) of epithelial cells and fibroblasts that drives the progression of pulmonary fibrosis. We describe the signaling molecules that mediate the interactions of these cell types in their fibrosis of two, including transforming growth factor-beta, connective tissue growth factor, sonic hedgehog, prostaglandin E-2, angiotensin II and reactive oxygen species. This article is part of a Special Issue entitled: Fibrosis: Translation of basic research to human disease. (C) 2013 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available